drugset / Trial / NCT00046722

Marijuana for HIV-Related Peripheral Neuropathy

NCT00046722 ↗

Phase 1/2 Completed 50 enrolled Center for Medicinal Cannabis Research
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate whether smoked marijuana reduces pain in people with HIV-related peripheral neuropathy.

Timeline

Start
2003-01
Primary completion
—
Completion
2005-04

Outcome

Met primary endpoint

paper Smoked cannabis reduced daily pain by 34% (median reduction; IQR = -71, -16) vs 17% (IQR = -29, 8) with placebo (p = 0.03). PMID 17296917 ↗

paper Greater than 30% reduction in pain was reported by 52% in the cannabis group and by 24% in the placebo group (p = 0.04). PMID 17296917 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabis Traditional medicine (herbal / TCM) 3.56 % Other